Enovis CorporationENOV

$21.97+1.12 (+5.37%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$1B
Small-cap
-42%
2016 — today
10-Year Price
-58%
2016 — today
52-Week Range
$20.85$35.94
Current $21.97· 7%

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.

Valuation in context

P/E ratio
-1.1
N/A
Not meaningful — company is unprofitable
P/B ratio
0.8
Above average
Pricier than usual over the last 10 years
FCF Yield
2.9%
Around average
Around the 10-year average
Free · No credit card needed

Get alerted when ENOV is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.